Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363974
Status:
COMPLETED
Last Update Posted:
2009-12-01
First Post:
2006-08-10
Brief Title:
Study of XIAP Antisense Given With Chemotherapy for RefractoryRelapsed AML
Sponsor:
Aegera Therapeutics
Organization:
Aegera Therapeutics
Organization Data
Organization:
Aegera Therapeutics
Class:
INDUSTRY
Study ID:
AEG35156-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Aegera Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jacques Jolivet MD Senior VP Clinical
Old Organization:
Aegera Therapeutics Inc